Aster Capital Management »

Urogen Pharma shares owned by Aster Capital Management

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Aster Capital Management from 13F filings

Historical chart of Aster Capital Management investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Aster Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Aster Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.0k 298 23.42

More positions owned by Aster Capital Management

Broadcom (AVGO)
Wal-Mart Stores (WMT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
First Tr Exchange-traded Dj Internt Idx (FDN)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Comcast Corp Cl A (CMCSA)
Microsoft Corporation (MSFT)
Spdr Series Trust State Street Spd (XHB)
Mettler-Toledo International (MTD)
Iqvia Holdings (IQV)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Waters Corporation (WAT)
Globalfoundries Ordinary Shares (GFS)

View all positions for Aster Capital Management

Top funds holding Urogen Pharma

Rtw Investments
Paradigm Biocapital Advisors
Toronto-Dominion Bank
BlackRock
Leucadia National Corporation
Silverarc Capital Management
Millennium Management
Acorn Capital Advisors
SG Americas Securities
American Century Companies
Menora Mivtachim Holdings
Healthcare Of Ontario Pension Plan Trust Fund
Caption Management
MPM Oncology Impact Management
D. E. Shaw & Co

View all funds holding Urogen Pharma